WGS to predict antibiotic MICs for Neisseria gonorrhoeae

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 7, 2017, Pages 1937-1947

  Eyre, David W ^a,b,c   Silva, Dilrini De ^a,b,c   Cole, Kevin ^d,e   Peters, Joanna ^d,e   Cole, Michelle J ^f   Grad, Yonatan H ^g,h   Demczuk, Walter ⁱ   Martin, Irene ⁱ   Mulvey, Michael R ⁱ   Crook, Derrick W ^a,b,c,e   Walker, A Sarah ^a,b,c   Peto, Tim E A ^a,b,c   Paul, John ^b,d,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b and University of Bristol   (United Kingdom)

^c Oxford National Institute for Health Research Health Protection Research Unit ^*  (United Kingdom)

^d UK   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f Public Health England   (United Kingdom)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CIPROFLOXACIN; PENICILLIN DERIVATIVE; TETRACYCLINE; ANTIINFECTIVE AGENT; PENICILLIN G;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; ENGLAND; GENETIC ANALYSIS; GENOTYPE; LEAVE ONE OUT CROSS VALIDATION; LINEAR REGRESSION ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIVARIATE ANALYSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PHENOTYPE; PREDICTION; RELIABILITY; STATISTICAL ANALYSIS; UNITED STATES; WHOLE GENOME SEQUENCING; BACTERIAL GENOME; DRUG EFFECTS; GENETICS; GONORRHEA; HIGH THROUGHPUT SEQUENCING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CANADA; CEFIXIME; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ENGLAND; GENOME, BACTERIAL; GONORRHEA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLIN G; TETRACYCLINE; UNITED STATES; WHOLE GENOME SEQUENCING;

EID: 85021792982     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx067     Document Type: Article

References (54)

1. Barbee LA. Preparing for an era of untreatable gonorrhoea. Curr Opin Infect Dis 2014; 27: 282-7.
2. PHE. Surveillance of Antimicrobial Resistance in Neisseria gonorrhoeae: Key Findings from the 'Gonococcal Resistance to Antimicrobials Surveillance Programme' (GRASP) and Related Surveillance Data, 2014. 2015. https://www. gov.uk/government/uploads/system/uploads/attachment_data/file/476582/ GRASP_2014_report_final_111115.pdf.
3. ECDC. Gonococcal Antimicrobial Susceptibility Surveillance in Europe 2016. http://ecdc.europa.eu/en/publications/Publications/gonococcalantimicrobial- susceptibility-surveillance-Europe-2014.pdf.
4. Kirkcaldy RD, Harvey A, Papp JR et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance-The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014.MMWRCDC Surveill Summ2016; 65: 1-19.
5. Public Health Agency of Canada. National Surveillance of Antimicrobial Susceptibilities of Neisseria gonorrhoeae Annual Summary 2014. 2015. http:// healthycanadians.gc.ca/publications/drugs-products-medicaments-produits /2014-neisseria/alt/surveillance-gonorrhoeae-2014-eng.pdf.
6. DemczukW,Martin I, PetersonSet al. Genomic epidemiology andmolecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J ClinMicrobiol 2016; 54: 1304-13.
7. Grad YH, Harris SR, Kirkcaldy RD et al. Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013. J Infect Dis 2016; 214: 1579-87.
8. Gordon NC, Price JR, Cole K et al. Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J ClinMicrobiol 2014; 52: 1182-91.
9. Stoesser N, Batty EM, Eyre DWet al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 2013; 68: 2234-44.
10. Walker TM, Kohl TA, Omar SV et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 2015; 15: 1193-202.
11. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27: 587-613.
12. Grad YH, Kirkcaldy RD, Trees D et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis 2014; 14: 220-6.
13. Unemo M, Golparian D, Śanchez-Buśo L et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother 2016; 71: 3096-108.
14. Li Y, Metcalf BJ, Chochua S et al. Penicillin-binding protein transpeptidase signatures for tracking and predicting b-lactam resistance levels in Streptococcus pneumoniae. MBio 2016; 7: e00756-16.
15. Metcalf BJ, Chochua S, Gertz RE et al. Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States. Clin Microbiol Infect 2016; 22: 1002.e1-e8.
16. De Silva D, Peters J, Cole K et al.Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study. Lancet Infect Dis 2016; 16: 1295-303.
17. Chisholm SA, Alexander S, Desouza-Thomas L et al. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England andWales.JAntimicrobChemother 2011; 66: 2509-12.
18. CDC, US Department of Health and Human Services. Gonococcal Isolate Surveillance Project (GISP) Protocol. http://www.cdc.gov/std/gisp/GISPProtocol07- 15-2010.pdf.
19. UnemoM, Fasth O, FredlundH et al. Phenotypic and genetic characterization of the 2008WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
20. EUCAST. Clinical Breakpoints-Bacteria (v 6.0). 2016. http://www.eucast. org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Break point_table.pdf.
21. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008; 18: 821-9.
22. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 2004; 32: 1792-7.
23. Li H, Durbin R. Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 2009; 25: 1754-60.
24. Li H, Handsaker B,Wysoker A et al. The sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25: 2078-9.
25. Unemo M, Golparian D, Nicholas R et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80.
26. US Department of Health and Human Services, FDA, Center for Devices and Radiological Health. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. 2009. http://www.fda.gov/ downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocu ments/ucm071462.pdf.
27. CDC, US Department of Health and Human Services. Neisseria gonorrhoeae Reference Strains for Antimicrobial Susceptibility Testing. 2005. https:// www.cdc.gov/std/gonorrhea/arg/b88-feb-2005.pdf.
28. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012; 7: 1401-22.
29. Earle SG, Wu C-H, Charlesworth J et al. Identifying lineage effects when controlling for population structure improves power in bacterial association studies. NatMicrobiol 2016; 1: 16041.
30. Didelot X, Bowden R, Wilson DJ et al. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 2012; 13: 601-12.
31. Guindon S, Dufayard J-F, Lefort V et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010; 59: 307-21.
32. OhnishiM, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
33. Bharat A, Demczuk W, Martin I et al. Effect of variants of penicillinbinding protein 2 on cephalosporin and carbapenem susceptibilities in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2015; 59: 5003-6.
34. Spratt BG. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae. Nature 1988; 332: 173-6.
35. Cousin SL Jr, Whittington WLH, Roberts MC. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. JAntimicrobChemother 2003; 51: 131-3.
36. Zarantonelli L, Borthagaray G, Lee EH et al. Decreased susceptibility to azithromycin and erythromycinmediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. J Antimicrob Chemother 2001; 47: 651-4.
37. Jacobsson S, Golparian D, Cole M et al. WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC.2mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. J Antimicrob Chemother 2016; 71: 3109-16.
38. Ohneck EA, Zalucki YM, Johnson PJT et al. A novel mechanism of highlevel, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio 2011; 2: e00187-11.
39. WarnerDM, ShaferWM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008; 70: 462-78.
40. OleskyM, HobbsM, Nicholas RA. Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 2811-20.
41. Zhao S, Duncan M, Tomberg J et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744-51.
42. Zhao S, Tobiason DM, Hu M et al. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol Microbiol 2005; 57: 1238-51.
43. OhnishiM, Ono E, Shimuta K et al. Identification of TEM-135 b-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan. Antimicrob Agents Chemother 2010; 54: 3021-3.
44. Palmer HM, Leeming JP, Turner A. Amultiplex polymerase chain reaction to differentiate b-lactamase plasmids of Neisseria gonorrhoeae. J Antimicrob Chemother 2000; 45: 777-82.
45. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single pointmutation in the 23S rRNA genes. Antimicrob Agents Chemother 2010; 54: 3812-6.
46. Ng L-K, Martin I, Liu G et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002; 46: 3020-5.
47. RobertsMC, ChungWO, Roe D et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43: 1367-72.
48. Rouquette-Loughlin CE, Balthazar JT, ShaferWM. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J Antimicrob Chemother 2005; 56: 856-60.
49. Luna VA, Cousin S,WhittingtonWL et al. Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother 2000; 44: 2503-6.
50. Belland RJ, Morrison SG, Ison C, Huang WM. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinoloneresistant isolates. MolMicrobiol 1994; 14: 371-80.
51. Rouquette-Loughlin C, Dunham SA, Kuhn M et al. The NorMefflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol 2003; 185: 1101-6.
52. Hu M, Nandi S, Davies C et al. High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants. Antimicrob Agents Chemother 2005; 49: 4327-34.
53. Morse SA, Johnson SR, Biddle JW et al. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 1986; 30: 664-70.
54. Gascoyne DM, Heritage J, Hawkey PM et al. Molecular evolution of tetracycline-resistance plasmids carrying TetM found in Neisseria gonorrhoeae fromdifferent countries. J Antimicrob Chemother 1991; 28: 173-83.